surmount-1 tirzepatide obesity nejm 2022 weight loss percent vs Semaglutide: Winner? π π 72-Week Data: Tirzepatide: ~20% body weight loss Semaglutide: ~14% body weight loss π‘ Tirzepatide shows greater weight & HbA1c reduction, but cost, side Tirzepatide for the Maintenance of
Description
Ketones are produced when the liver breaks down fat

Hunger returns in waves

Mounjaro (tirzepatide) for Type 2 Diabetes : Approved in May 2022 as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Retrieved from MedlinePlus

Study design: Trial type: Open-label, active-controlled, randomized, parallel-group superiority trial

Injection site reactions are reported by some tirzepatide users and should not be confused with autoimmune skin flares
